Rupture of Hepatic Hemangioma Following Living Donor Liver Transplantation: A Case Report
- PMID: 40589300
- DOI: 10.1111/petr.70122
Rupture of Hepatic Hemangioma Following Living Donor Liver Transplantation: A Case Report
Abstract
Background: Hepatic hemangiomas are common benign liver tumors, typically asymptomatic with a low complication rate in liver transplantation (LT). However, post-transplant rupture, though rare, can result in significant morbidity. This report describes the rupture of a small hepatic hemangioma in a liver graft following pediatric living donor liver transplantation (LDLT).
Case report: An 11-month-old boy with biliary atresia underwent LDLT using a left lateral segment from his healthy mother. Preoperative imaging revealed a 2x3 cm hemangioma in Segment III of the donor's liver. Post-transplant, the child experienced significant bleeding 4 h after surgery, leading to hemodynamic instability and a drop in hemoglobin. Re-exploration revealed a large hematoma and rupture at the hemangioma site. Additional resection of the hemangioma and hematoma was performed. The child recovered after a prolonged ICU stay and remains well after 8 years of follow-up.
Discussion: Hepatic hemangiomas are generally asymptomatic, but rupture post-transplant can lead to severe complications. There is no standardized approach for managing hemangiomas in liver grafts. This case highlights the need for careful evaluation of lesion size, location, and potential vascular and biliary implications in donor selection. Further research is needed to define optimal management strategies for liver graft hemangiomas.
Conclusion: While rare, hepatic hemangiomas in liver grafts require careful evaluation, with further studies needed to establish management protocols.
Keywords: children; hepatic artery thrombosis; liver transplantation; living donation; outcomes.
© 2025 Wiley Periodicals LLC.
References
-
- European Association for the Study of the L. EASL, “Clinical Practice Guidelines on the Management of Benign Liver Tumours,” Journal of Hepatology 65, no. 2 (2016): 386–398, https://doi.org/10.1016/j.jhep.2016.04.001.
-
- N. Bajenaru, V. Balaban, F. Savulescu, I. Campeanu, and T. Patrascu, “Hepatic Hemangioma ‐Review,” Journal of Medicine and Life 8, no. Spec Issue (2015): 4–11.
-
- S. Althaus, B. Ashdown, D. Coldwell, W. S. Helton, and P. C. Freeny, “Transcatheter Arterial Embolization of Two Symptomatic Giant Cavernous Hemangiomas of the Liver,” Cardiovascular and Interventional Radiology 19, no. 5 (1996): 364–367, https://doi.org/10.1007/BF02570193.
-
- V. Jain, V. Ramachandran, R. Garg, S. Pal, S. R. Gamanagatti, and D. N. Srivastava, “Spontaneous Rupture of a Giant Hepatic Hemangioma ‐ Sequential Management With Transcatheter Arterial Embolization and Resection,” Saudi Journal of Gastroenterology 16, no. 2 (2010): 116–119, https://doi.org/10.4103/1319‐3767.61240.
-
- H. L. Candido, E. A. da Fonseca, F. H. Feier, et al., “Risk Factors Associated With Increased Morbidity in Living Liver Donation,” J Transplant (2015): 1–8, https://doi.org/10.1155/2015/949674.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical